Medxy AI

eHealth-Guided Exercise Enhances Peak Oxygen Uptake and Quality of Life Post-COVID-19: A Randomized Controlled Trial

By MedXY 11/02/2026

This trial shows that a six-month eHealth-guided exercise program significantly improves peak oxygen uptake and mental health quality of life in adults recovering from COVID-19, outperforming standard physical activity advice.

Clinical Updates Orthopedics

Five-Year Outcomes of Arthroscopic Bankart Repair in Young Athletes With Minimal Glenoid Bone Loss: Recurrence, Return to Sport, and Risk Factors

By MedXY 11/01/2026

Arthroscopic Bankart repair in young patients with minimal glenoid bone loss shows high clinical improvement and return to sport but a considerable recurrence rate, especially among contact sport athletes, highlighting the need for careful risk assessment.

Clinical Updates Neurology Rehabilitation Medicine

Age-Related Differences Influence Outcomes of Long-Term Multimodal Stroke Intervention: Insights from the LAST-long Trial

By MedXY 11/01/2026

The LAST-long trial investigated a community-based, individualized stroke intervention and found that age—but not frailty—significantly modifies its effectiveness, with older stroke survivors (≥80 years) experiencing less favorable outcomes compared to younger patients.

Clinical Updates Gastroenterology Oncology

Linking Oral Health to Liver Cancer Risk: Insights from a Nationwide Swedish Cohort Study

By MedXY 11/01/2026

A large Swedish cohort study reveals that dental diseases and tooth loss are associated with increased risk of primary liver cancer, highlighting the importance of oral health in systemic disease prevention.

Clinical Updates Hematology-Oncology

Mitapivat in Sickle Cell Disease: A Promising Oral Therapy to Improve Hemolytic Anemia and Reduce Complications

By MedXY 11/01/2026

The phase 3 RISE UP trial demonstrates that mitapivat significantly improves hemoglobin levels in sickle cell disease, offering a novel, well-tolerated oral treatment with potential to modify disease outcomes.

Clinical Updates Neurology Pediatrics

Hydrocephalus: Advances in Treatment, Emerging Research, and Ongoing Challenges

By MedXY 11/01/2026

Hydrocephalus is a multifaceted neurological disorder caused by cerebrospinal fluid imbalance. This review explores current surgical treatments, emerging technologies, molecular mechanisms, and challenges in managing hydrocephalus effectively.

Allergy & Immunology Clinical Updates Rheumatology

Isotype-Specific Autoantibody Remodeling in Antiphospholipid Syndrome via BAFF-APRIL Blockade

By MedXY 11/01/2026

This study reveals that dual BAFF-APRIL blockade with telitacicept distinctly remodels pathogenic autoantibodies in antiphospholipid syndrome, showing differential effects across immunoglobulin isotypes and identifying marrow plasma-cell clonotypes linked to persistent IgG autoantibodies.

Cardiology Clinical Updates

Energetic Recovery and Myocardial Efficiency After Heart Transplantation: Insights from an Exploratory Study

By MedXY 11/01/2026

This study explores myocardial external efficiency (MEE) and mitochondrial function in heart transplant recipients, revealing improved MEE at 6 months post-transplant associated with myocardial contractility and biomarkers, highlighting energetic adaptation during early graft recovery.

Clinical Updates Dermatology

Comparative Effectiveness and Safety of HMME-PDT Versus Pulsed Dye Laser in Treating Facial and Neck Port-Wine Stains: Insights from a Large Retrospective Study

By MedXY 11/01/2026

A retrospective analysis reveals hematoporphyrin monomethyl ether-mediated photodynamic therapy (HMME-PDT) outperforms pulsed dye laser (PDL) in clearing facial and neck port-wine stains but with an increased risk of hyperpigmentation and scarring.

Cardiology Clinical Updates Critical Care

Clinical Implications of Brachial-to-Radial Arterial Pressure Gradients in Critically Ill Patients on Vasoactive Therapy

By MedXY 11/01/2026

A significant brachial-to-radial arterial pressure gradient occurs in nearly one-fifth of critically ill patients receiving vasoactive agents, correlating with higher vasoactive doses, greater illness severity, and increased ICU mortality.

Clinical Updates Internal Medicine Psychiatry

Hospital Discharge Prescriptions for Alcohol Use Disorder: Unveiling Key Predictors to Bridge the Treatment Gap

By MedXY 11/01/2026

Despite proven benefits, medications for alcohol use disorder remain underprescribed at hospital discharge. This study identifies hospitalization and patient factors influencing new prescriptions, highlighting opportunities to enhance AUD treatment integration in inpatient settings.

Clinical Updates Hematology-Oncology

Innovative Thrombin-Responsive AutoRegulated FVIII-Mimetic Antibodies for Safer Hemophilia A Therapy

By MedXY 11/01/2026

A novel thrombin-cleavable FVIII-mimetic antibody enables dynamic, on-demand control of coagulation, reducing adverse thrombotic risk while maintaining efficacy in hemophilia A treatment.

Clinical Updates Public Health Respiratory

Navigating Barriers to Lung Cancer Screening Follow-Up in Community Care: Insights from the ACCELL Trial

By MedXY 11/01/2026

This study identifies key organizational, social, and individual determinants affecting lung cancer screening follow-up in community settings, highlighting strategies to improve adherence and optimize mortality benefits.

Clinical Updates Ophthalmology

Recurrent Visual Field Progression in Glaucoma: Incidence, Risk Factors, and Clinical Implications

By MedXY 11/01/2026

A cohort study identifies key risk factors such as faster baseline visual field loss, higher post-progression intraocular pressure, and older age that predict recurrence of visual field progression in glaucoma, emphasizing the need for personalized monitoring and therapy intensification.

Clinical Updates Otorhinolaryngology

Perception of Low-Frequency Musical Sound Quality in Hearing-Assistive Devices: Comparing Hearing Aids and Cochlear Implants

By MedXY 11/01/2026

This study evaluates how users of hearing aids and cochlear implants perceive musical sound quality when low-frequency components are degraded, revealing significant differences in sensitivity relevant to patient counseling and device optimization.

Clinical Updates Gastroenterology General Surgery

Pancreatic Fistula and Intra-abdominal Fluid Collections After Distal Pancreatectomy: Incidence, Clinical Impact, and Management Strategies

By MedXY 11/01/2026

This study analyzes the incidence and clinical consequences of pancreatic fistulas and intra-abdominal fluid collections following distal pancreatectomy, highlighting their management and the impact of surgical drain placement.

Clinical Updates OB/GYN & Women's Health

Enhancing Follow-Up After Early Medical Abortion in New Zealand: Evidence from a Randomised Controlled Trial on Self-Assessment versus Serum bhCG Testing

By MedXY 11/01/2026

A New Zealand RCT demonstrates that self-assessment with low sensitivity urine pregnancy tests after early medical abortion improves complete follow-up and successful abortion rates compared to serum bhCG testing, supporting safer, equitable reproductive healthcare.

Clinical Updates Diabetes & Endocrinology Gastroenterology

Miricorilant in Metabolic Dysfunction-Associated Steatohepatitis: Promising Phase 1b Results Highlight Intermittent Dosing Strategy

By MedXY 11/01/2026

This phase 1b study of miricorilant, a selective glucocorticoid receptor modulator, shows significant reductions in liver fat and improvements in liver health markers in patients with presumed metabolic dysfunction-associated steatohepatitis, particularly with intermittent dosing.

Clinical Updates Neurology

Antidopaminergic Medications and Clinical Outcomes in Huntington Disease: Insights From the PROOF-HD Placebo-Controlled Trial

By MedXY 11/01/2026

This review synthesizes evidence from the PROOF-HD placebo arm and related studies, demonstrating that antidopaminergic medication use in Huntington disease correlates with accelerated decline in functional, motor, and cognitive outcomes, emphasizing the need for careful consideration in clinical trials and management.

Clinical Updates Diabetes & Endocrinology Pediatrics

Lonapegsomatropin Once-Weekly Therapy Shows Comparable Efficacy to Daily Somatropin in Turner Syndrome: 52-Week Outcomes from the New InsiGHTS Trial

By MedXY 11/01/2026

This phase 2 trial demonstrates that once-weekly lonapegsomatropin matches daily somatropin in improving height velocity and safety in children with Turner syndrome over 52 weeks, offering a promising alternative to daily injections.